0001651308-24-000036.txt : 20240411
0001651308-24-000036.hdr.sgml : 20240411
20240411180141
ACCESSION NUMBER: 0001651308-24-000036
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240409
FILED AS OF DATE: 20240411
DATE AS OF CHANGE: 20240411
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: OYLER JOHN
CENTRAL INDEX KEY: 0001042047
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37686
FILM NUMBER: 24839558
MAIL ADDRESS:
STREET 1: C/O GENTA INC
STREET 2: 3550 GENERAL ATOMICS CT BLDG 9
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BeiGene, Ltd.
CENTRAL INDEX KEY: 0001651308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 981209416
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
BUSINESS PHONE: 13459494123
MAIL ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
4
1
wk-form4_1712872891.xml
FORM 4
X0508
4
2024-04-09
0
0001651308
BeiGene, Ltd.
BGNE
0001042047
OYLER JOHN
C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
94 SOLARIS AVENUE
CAMANA BAY, GRAND CAYMAN
E9
KY1-1108
CAYMAN ISLANDS
1
1
0
0
Chief Executive Officer
1
Ordinary Shares
1321554
D
Ordinary Shares
481533
I
See Footnote
Ordinary Shares
7727927
I
See Footnote
Ordinary Shares
28334115
I
See Footnote
Ordinary Shares
9545000
I
See Footnote
Ordinary Shares
102188
I
See Footnote
American Depositary Shares
2024-04-09
4
S
0
542
152.2839
D
49458
I
See Footnote
American Depositary Shares
2024-04-09
4
S
0
2734
153.472
D
46724
I
See Footnote
American Depositary Shares
2024-04-09
4
S
0
7924
154.2084
D
38800
I
See Footnote
American Depositary Shares
2024-04-10
4
S
0
11514
148.3962
D
27286
I
See Footnote
American Depositary Shares
2024-04-10
4
S
0
12501
149.1539
D
14785
I
See Footnote
American Depositary Shares
2024-04-10
4
S
0
2641
149.7931
D
12144
I
See Footnote
American Depositary Shares
2024-04-10
4
S
0
60
150.85
D
12084
I
See Footnote
American Depositary Shares
2024-04-11
4
S
0
5008
146.088
D
7076
I
See Footnote
American Depositary Shares
2024-04-11
4
S
0
4265
146.816
D
2811
I
See Footnote
American Depositary Shares
2024-04-11
4
S
0
2811
147.7432
D
0
I
See Footnote
These securities are held by the P&O Trust, the beneficiaries of which include the Reporting Person's child and others, for which the Reporting Person disclaims beneficial ownership.
These securities are held in a grantor retained annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
These securities are held by Oyler Investment LLC, of which 99% of the the limited liability company interest owned by a grantor retain annuity trust, of which the Reporting Person's father is a trustee, for which the Reporting Person disclaims beneficial ownership.
These securities are held for the benefit of the Reporting Person in a Roth IRA PENSCO trust account.
These securities are held by The John Oyler Legacy Trust, of which the Reporting Person's father is a trustee, for the benefit of the Reporting Person's minor child, for which the Reporting Person disclaims beneficial ownership.
Each American Depositary Share represents 13 Ordinary Shares.
The sale was effected pursuant to a Rule 10b5-1 trading plan adopted on December 12, 2023.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $151.83 to $152.82, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $152.88 to $153.87, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $153.88 to $154.83, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.66 to $148.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $148.66 to $149.65, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $149.66 to $150.34, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $145.39 to $146.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $146.39 to $147.38, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $147.39 to $148.11, inclusive. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of American Depositary Shares sold at each separate price.
/s/ Qing Nian, as Attorney-in-Fact
2024-04-11